Asset
Aspirin
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00814268 | phase4 | completed | 2008-12-01 | 2012-05-01 | Sanofi | COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke |
| NCT03794336 | phase4 | completed | 2019-06-29 | 2020-12-14 | Sanofi | Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 016891 | NDA | SANOFI AVENTIS US LLC |
Marketed products (1)
- TALWIN COMPOUND